Elevra Lithium Limited (ASX:ELV) Corporate Presentation - Outlines NAL Operating Performance and Staged Expansion Plans
Elevra Lithium (ASX:ELV, NASDAQ:ELVR) reported Q1 FY27 production of 54,907 dmt of spodumene concentrate, with unit costs down 14% QoQ. It outlined expansion plans for North American Lithium, targeting capacity growth to 373ktpa. The company also detailed supply agreements and financials, including Q1 revenue of US$74 million and cash of US$319 million.





